Development of a novel fluorogenic assay method for screening inhibitors of bovine leukemia virus protease and identification of mitorubrinic acid as an anti-BLV compound

被引:1
|
作者
Murakami, Hironobu [1 ,2 ]
Fujikawa, Yuuta [3 ]
Mori, Masaya [3 ]
Mosu, Nozomi [1 ]
Taguchi, Akihiro [4 ]
Hayashi, Yoshio [4 ]
Inoue, Hideshi [3 ]
Kamisuki, Shinji [1 ,2 ]
机构
[1] Azabu Univ, Sch Vet Med, Sagamihara, Kanagawa, Japan
[2] Azabu Univ, Ctr Human & Anim Symbiosis Sci, Sagamihara, Kanagawa, Japan
[3] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Hachioji, Tokyo, Japan
[4] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo, Japan
基金
日本学术振兴会;
关键词
fluorogenic assay; protease inhibitor; bovine leukemia virus; mitorubrinic acid; MILK-PRODUCTION; INFECTION; PRODUCTIVITY; ASSOCIATION; FUNGUS;
D O I
10.1093/bbb/zbad073
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bovine leukemia virus (BLV) causes enzootic bovine leukosis, a fatal cattle disease that leads to significant economic losses in the livestock industry. Currently, no effective BLV countermeasures exist, except testing and culling. In this study, we developed a high-throughput fluorogenic assay to evaluate the inhibitory activity of various compounds on BLV protease, an essential enzyme for viral replication. The developed assay method was used to screen a chemical library, and mitorubrinic acid was identified as a BLV protease inhibitor that exhibited stronger inhibitory activity than amprenavir. Additionally, the anti-BLV activity of both compounds was evaluated using a cell-based assay, and mitorubrinic acid was found to exhibit inhibitory activity without cytotoxicity. This study presents the first report of a natural inhibitor of BLV protease-mitorubrinic acid-a potential candidate for the development of anti-BLV drugs. The developed method can be used for high-throughput screening of large-scale chemical libraries. [GRAPHICS] .
引用
收藏
页码:946 / 953
页数:8
相关论文
empty
未找到相关数据